Dynavax Technologies Corporation (DVAX)

Financial leverage ratio

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Total assets US$ in thousands 986,256 1,061,990 1,016,320 986,565 997,096 972,933 936,432 969,922 985,850 999,337 1,023,000 1,008,980 1,039,250 919,711 647,909 490,119 353,272 353,395 329,314 259,256
Total stockholders’ equity US$ in thousands 596,799 681,427 642,849 618,480 622,072 604,916 577,205 563,732 581,013 500,576 422,799 287,484 222,374 67,576 83,380 99,762 58,693 69,284 58,295 11,824
Financial leverage ratio 1.65 1.56 1.58 1.60 1.60 1.61 1.62 1.72 1.70 2.00 2.42 3.51 4.67 13.61 7.77 4.91 6.02 5.10 5.65 21.93

December 31, 2024 calculation

Financial leverage ratio = Total assets ÷ Total stockholders’ equity
= $986,256K ÷ $596,799K
= 1.65

The financial leverage ratio of Dynavax Technologies Corporation has shown a general decreasing trend over the years, indicating a reduction in the company's reliance on debt to finance its operations. The ratio decreased from 21.93 as of March 31, 2020, to 1.65 as of December 31, 2024.

This decreasing trend suggests that the company has been gradually decreasing its debt levels relative to its equity, which can be seen as a positive sign of financial stability and resilience. A lower financial leverage ratio indicates that the company has less debt risk and is less vulnerable to financial distress in times of economic uncertainty.

Overall, the decreasing trend in Dynavax Technologies Corporation's financial leverage ratio reflects a prudent approach to managing its capital structure and mitigating financial risks.